Details for New Drug Application (NDA): 019979
✉ Email this page to a colleague
The generic ingredient in TICLID is ticlopidine hydrochloride. There are nine drug master file entries for this compound. Additional details are available on the ticlopidine hydrochloride profile page.
Summary for 019979
Tradename: | TICLID |
Applicant: | Roche Palo |
Ingredient: | ticlopidine hydrochloride |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 019979
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 125MG | ||||
Approval Date: | Mar 24, 1993 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 250MG | ||||
Approval Date: | Oct 31, 1991 | TE: | RLD: | No |
Expired US Patents for NDA 019979
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Roche Palo | TICLID | ticlopidine hydrochloride | TABLET;ORAL | 019979-001 | Mar 24, 1993 | ⤷ Sign Up | ⤷ Sign Up |
Roche Palo | TICLID | ticlopidine hydrochloride | TABLET;ORAL | 019979-002 | Oct 31, 1991 | ⤷ Sign Up | ⤷ Sign Up |
Roche Palo | TICLID | ticlopidine hydrochloride | TABLET;ORAL | 019979-002 | Oct 31, 1991 | ⤷ Sign Up | ⤷ Sign Up |
Roche Palo | TICLID | ticlopidine hydrochloride | TABLET;ORAL | 019979-001 | Mar 24, 1993 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription